3Lvermore DM. Determinants of the activity of the β-lactamase inhibitor combinations. J Antimicrob Chemother,1993, 31(supp 1.A): 9-21.
4Noskin GA,Pietrelli L,Coffey G,et al.Amphotericin B colloidal dispersion for treatment of candidemia in immunocompromised patients.Clin Infect Dis,1998,26:461-467.
5Nieto-Rodriguez JA,Kusne S,Manez R,et al.Factors associated with the development of Candidemia:related death among liver transplant recipients.Am Surg,1996,223:70.
6Mizushima Y,Li H,Yoshida I,et al.Changes in clinical features of fungemia in a Japanese University Hospital over a 12-Year period.Intern Med,1996,35:707-711.
7Kauffman CA.When to suspect fungal infection as the cause of nonresolving pneumonia.J Respir Dis,1999,20:283-293.
